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1. Introduction
Tuberculosis (TB) is a major public concern and is the most important single infectious cause
of mortality and morbidity worldwide. According the World Health Organization (WHO)
records, in 2009, there were an estimated 9.4 million new cases, 14 million prevalent cases, and
approximately 1.7 million deaths by TB [1]. Additionally, approximately one third of the
world’s population is infected with the causative bacterium, Mycobacterium tuberculosis (Mtb),
and is at risk for developing active tuberculosis. Interestingly, while approximately 9 million
people develop active TB each year, the majority remain asymptomatically (latently) infected
with the pathogen presumably due to a protective immune response. Without intervention,
approximately five to ten percent of those latently infected will develop overt disease and the
potential to transmit Mtb to others [2].
Familial clustering data, twin studies and complex segregation analysis have all suggested a
strong genetic component in the human susceptibility to the chronic mycobacterial diseases
[3-7] but also a complex picture of geographic heterogeneity in genetic effects on the different
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mycobacterial infections is involved [8, 9]. Several non-HLA genes have been implicated in TB
susceptibility. However, the discrepant data reported may be attributed to a number of
different factors, such as the types of studies, ethnicity, genetic background, and clinical status
of patients with tuberculosis that may be associated with a particular genetic profile. The
interaction among lung cells with pro and anti-inflammatory mediators during the infection
with Mtb have been deeply investigated [10]. Among involved cytokines, the key role of
interferon-gamma (IFN-γ) and tumor necrosis factor (TNF-α) in eliciting an inflammatory
response against Mtb have been emphasized [11-13].
In human studies, the crucial role of TNF-α in protective host immunity against reactiva‐
tion of latent TB was highlighted by the observation that the relapse and severe course of
TB is  over-represented in  rheumatoid arthritis  patients  following the  use  of  anti-TNF-α
antibodies [14]. Concerning the IFN-γ, it is well established that deficiency in IFN-γ gene
expression is  associated with severe impairment of  resistance to infections,  in particular
those  that  are  normally  killed by activated macrophages  [15,  16].  Low synthesis  of  this
cytokine has  been associated with active tuberculosis  [17].  However,  on the contrary of
TNF-α,  the  Interferon gamma conding gene  (IFNG)  is  highly  conserved and few single
nucleotide polymorphisms (SNPs) are found in the intragenic region. Several case-control
studies  to  evaluate  association  of  SNPs  in  these  genes  with  TB  have  produced  mixed
results, with little consensus in most cases on whether any TNF polymorphisms are actually
associated with active TB disease [18, 19].
In the present study we aimed to analyse the existing promoter variability of the IFNG and
TNF-α genes by partial mapping of this region in samples from Brazilians, followed by an
association study of the identified SNPs and TB outcome after infection with Mtb.
2. Method used
2.1. Study population
In a case-control design, five hundred consanguineously unrelated individuals admitted at
the University Hospital Complex: Thoracic Institute/ClementinoFraga University Hospital
from Federal University of Rio de Janeiro-UFRJ were enrolled in this study after signing
informed consent approved by the local Ethics Committee of HUCFF-UFRJ.
Demographic, clinical, and microbiological data as well as the HIV status of the subjects (age
> 18 years old) were collected. Active TB cases (n=265) were defined as those after a positive
culture confirmation in clinical specimen or with clinical, radiographic and laboratory
improvement according to the American Thoracic Statements.They comprised 265 TB patients
to be used for the descriptive genetic analysis. For the association study, TB-HIV comorbity
was considered as an exclusion criteria and sample size was reduced as follow: 140 TB patients,
being 121 with pulmonary TB (PTB) and 19 extrapulmonary forms of TB (TBE). The mean age
of TB patients was ± 51 years (range 18-84 years) including 73 males and 67 females.
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For the control group, a complete questionnaire to document TB risk factors since baseline
testing was used. Individuals were eligible as controls if they had no previous TB history,
consanguinity and negative HIV status. In formations concerning Tuberculin Skin Test (TST)
response were available for all controls. They comprised 235 individuals, to be used for
descriptive genetic analysis. For the association study, after application of the exclusion
criteria, 154 individuals were included in this group, of which, 96 were TST positive (TST+)
and 58 TST negative (TST-). The mean age in this group was ± 50 (range 18 - 82 years) and
included 55 males and 99 females.
Sample Collection and handling
A volume of 3 mL of venous blood was collected from each volunteer and stored at -20°C.
Genomic DNA was isolated from 100 µL of frozen whole blood using the FlexiGene DNA Kit
(Qiagen Inc., USA), according to the manufacturer’s specifications. After extraction, DNA
samples were stored at -20°C.
2.2. IFNG and TNF–α genotyping
Genotyping of the proximal portion of the promoter region in TNF-α and IFNG genes was
achieved by direct sequencing of PCR products.  Two sets of primers for PCR amplifica‐
tion and sequencing of IFNG, DNA fragment of 863bp, (IFN-EF: 5’ GGAACTCCCCCTGG‐
GAATATTCT  3`,  IFNER:  5´AGCTGATCAGGTCCAAAGGA3´,  IFNIF:  5
´CGAAGTGGGGAGGT  ACAAAA  3´  and  IFNIR:  5´  CCCAGGAAACTGCTACTCTG  3´),
and TNF-α, DNA fragment of 855bp (TNFEF: 5´CAGGACCTCCAGGTATGGAA3´, TNFER:
5’ TAGCTGGTCCTCTGCTGTCC3’, TNFIF: 5´CCTGCATCCTGTCTGGAAGT 3´ and TNF-
IR: 5’TTTCAACCCCTGTGTGTTCG 3’) were designed by using the Primer3 software [20].
For PCR-mediated DNA amplification of IFNG, 100 ng of genomic DNA were added to a
50µL reaction mixture containing 200ng of each primer (IFN-EF and IFN-ER),  0.2mM of
each dNTPs,  2.0mM MgCl2  and 1U Taq  DNA polymerase (Invitrogen by Life  Technolo‐
gies,  USA) and submitted to  an initial  denaturation at  94°C for  5  min.,  followed by 35
cycles  of  1  min.  at  94°C,  1  min.  at  65.3°C and 1  min at  72°C.  Final  extension was per‐
formed for 5 min. at 72°C. Likewise, for amplification of the 855pb TNF-α fragment, 100ng
of genomic DNA were added to a 25µL reaction mixture containing 200ng of each primer
(TNF-EF and TNF-ER),  2mM MgCl2,  0.2mM of each dNTPs and 0.5U of  Taq  gold DNA
polymerase (PE Applied BioSystems) and submitted to initial denaturation at 94°C for 15
min, followed by 35 cycles of 1 min. at 94°C, 1 min. at 65.9°C and 1 min at 72°C with a
final extension at 72°C for 5 min. Evaluation of PCR products was done by electrophore‐
sis on 1.2% agarose gel followed by ethidium bromide staining.
For sequencing, PCR products were purified with ChargeSwitch Kit (Invitrogen Life Tech‐
nologies), according to the manufacturer’s recommendations. Sequencing of the amplified
fragments was performed in both DNA strands using a combination of the internal and
external primers using ABI PRISM Big Dye Terminator v. 3.1 Kit (PE Applied BioSystems),
according to the manufacturer’s recommendations, on an ABI PRISM 3730 DNA Analyser (PE
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Applied BioSystems). All singletons and even new/rare mutation identified were confirmed
by re-amplification and re-sequencing.
2.3. Computational analysis
The SNPs identification in each individual sample was achieved after alignment of the
generated sequences with the GenBank reference sequences AF3757790 and AB088112 for
IFNG and TNF-α respectively. Transcription starting site sequence definition adopted for both
genes considered as starting point, the first nucleotide immediately preceding position (-1) out
of mRNA. Sequence analysis was carried out through SeqScapev. 2.6 software (Applied
Biosystem). Haplotype reconstruction was achieved through the use of PHASE Vs. 2.1.1
software [21, 22].
2.4. Statistical analysis
Pair-wise linkage disequilibrium was tested for the loci studies. The Hardy-Weinberg equili‐
brium using χ2 test. Statistics were performed in XLSTAT 2008.7 (Addinsoft Software Inc -
New York USA). The magnitude of the associations was estimated by odds ratio values and
the coefficient of associations. All tests were performed at the 0.05 level of significance by Epi
Info version 3.5.1 2008 (Centers for Disease Control and Prevention, USA).
3. Results
In this work, a partial mapping of the promoter regions of IFNG and TNF-α genes was
performed by direct PCR sequencing approach in 265 TB patients and 235 healthy controls
residents in Rio de Janeiro, Brazil. Sequencing approach allowed the identification of new SNPs
and consequently new haplotypes for both genes. Expected genotype frequencies were
calculated from respective single allele frequencies and were consistent with Hard Weinberg
Equilibrium using χ2test.
3.1. Partial mapping of the IFNG promoter region in samples from Brazilians residents in
Rio de Janeiro
Sequence analysis of the proximal portion of IFNG promoter region (863 bp upstream of the
transcription starting site) revealed the presence of seven SNPs, of which, four were new, and
located at positions (-787C>T, -599C>G, -517C>T, and -255A>G). The three remaining SNPs,
already deposited in GenBank-Entrez SNP database, were located at positions (-785C>T,
-200G>T, reported as (-183 and -179) and -172A>G (reported as -155). Table 1 show the allele
and genotype frequencies of the identified SNPs in the whole studied population (500
samples). All SNPs were found in a very low frequency, sometimes as a singleton (-255A>G).
In this case, the SNP was confirmed by new PCR amplification and re-sequencing. The two
more frequent SNPs were the ones located at positions -599C>G and -200G>T, both with 1.4%.
No homozygosity was identified in these positions.
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Locus
IFNG Genotype
Subjects
(n = 500) Absolute Frequency
Allele
frequency
CC 495 0.99
-787* TC 5 .001 0.05
(f) T 5 _
CC 495 0.99
-785 CT 5 0.01 0.05
(f) T 5 _
CC 487 0.974
-599* CG 12 0.024
GG 1 0.002 0.014
(f) G 2 -
CC 497 0.994
-517* CT 3 0.06 0.003
(f)T 3 -
AA 499 0.998
-255* AG 1 0.002 0.001
1 -
(f) G
GG 486 0.972
-200 GT 14 0.028 0.014
(f) T 14 -
AA 498 0.996
-172 AG 2 0.004 0.002
(f) G 2
Table 1. Genotype and allele frequencies of SNPs within IFNG promoter in Brazilians from Rio de Janeiro.
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3.2. IFNG haplotypes characterization
Haplotype reconstruction was achieved from genotyping data by using Phase Vs. 2.1.1
software. A total of eight different haplotypes were characterized with basis on the combina‐
tion of the seven SNPs identified within the IFNG promoter. Table 2 shows the frequencies of
the identified haplotypes in the total population. The haplotype 4 was the, more frequent
among the whole samples analyzed.
Haplotypes -787 -785 -599 -517 -255 -200 -172 Frequency
1 C C C C A G A 0.916
2 C T C C A G A 0.010
3 C C G C A G A 0.024
4 C C C C A T A 0.028
5 T C C C A G A 0.010
6 C C C C G G A 0.002
7 C C C C A G G 0.004
8 C C C T A G A 0.006
Table 2. Characterization of the identified haplotypes within IFNG proximal promoter region in Brazilians from Rio de
Janeiro (n=500).
3.3. Partial mapping of the TNF–α promoter region in samples from Brazilians residents in
Rio de Janeiro
The partial mapping of the proximal portion (855 bp upstream of the transcription starting
site) of TNF-α promoter was also performed by direct sequencing of PCR products. Upon
analysis of the generated sequences seven SNPs, all described in the literature, and were
identified in a total of 500 samples. Table 3 shows the allele and genotype frequencies. With
the exception of the most studied SNPs (-238 -308, and -376) presenting frequencies higher
than 3%, all others were present in less than one percent.
3.4. TNF–αhaplotypes characterization
A total of fourteen different haplotypes were characterized. Except for the wild-type, haplo‐
type 1, the higher frequent was the haplotype 3, presenting a mutant variation only at -308
position. As expected, the rare combination presenting polymorphisms only at positions -238
and -308 was present in the sample studied although in a low frequency (Table 4).
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Locus Genotype Subjects(n=500)
Absolute
Frequency
Allele
Frequency
GG 495 0.990 -
-646 GA 5 0.010 -
A 5 _ 0.005
AA 495 0.990 -
-572 AC 5 0.010 -
C 5 _ 0.005
CC 499 0.998 _
-422 CT 1 0.002 _
T 1 _ 0.001
GG 471 0.942 _
-376 GA 28 0.056 _
AA 1 0.002 _
A 30 _ 0.030
GG 418 0.836 _
-308 GA 77 0.154 _
AA 5 0.010 _
A 87 _ 0.087
GG 489 0.978 _
-244 GA 11 0.022 _
A 11 _ 0.011
GG 453 0.906 _
-238 GA 44 0.088 _
AA 3 0.006 _
A 50 _ 0.050
Table 3. Genotype and allele frequencies of SNPs within TNF-α promoter in Brazilians from Rio de Janeiro.
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Haplotype -646 -572 -422 -376 -308 -238 -244 Frequency
1 G A C G G G G 0.710
2 G A C A G G G 0.006
3 G A C G A G G 0.146
4 G C C G G G G 0.006
5 G A C G G G A 0.020
6 G A C G G A G 0.040
7 A A C G G G G 0.008
8 G A T G G G G 0.002
9 G A C A G A G 0.044
10 G A C A A A G 0.060
11 G A C A A G G 0.002
12 G A C G A G A 0.002
13 G A C G A A G 0.004
14 G C C G A G G 0.004
Table 4. Haplotypes description and frequencies within TNF-α promoter in Brazilians from Rio de Janeiro.
3.5. Association of the IFNG SNPs and TB outcomes
Association of the identified SNPs variations within the analyzed region ofIFNG with different
TB outcomes (susceptibility per se, protection, severity and susceptibility to latent M. tubercu‐
losis infection) was assessed based in the comparison of allele, genotype and haplotype
frequencies between the stratified groups. The groups used for each evaluation were as follow:
a) susceptibility per se to TB (TB patients versus TST+ controls), b) disease severity (PTB versus
TBE) and c) susceptibility to the latent infection (healthy controls TST+ versus TST-).
As previously stated, for this analysis, the sample size was reduced in groups, (patients and
controls) because of the exclusion criteria of TB-HIV co-infection and consanguinity. After
exclusions, because of the very low frequency of the -255 A>G and -172 A>G these SNPs were
also excluded.
Results of the association study upon comparison of genotype frequencies of the five remaining
SNPs between TB patients (TBP/EPTB) versus TST+ controls are shown in Table 5. Only the
SNP -200G>T presented a significantly higher frequency of the GT genotype in the control
group indicating an association of this genotype with protection to the occurrence of active TB
(χ2 = 3.86, p = 0.033, OR = 0.18 CI = 0.03 -1.00). Evaluation of the identified SNPs with the other
outcomes did not show any association (data not shown).
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Loci Genotype Patientes(N=140)
Controls TST+* (N=
96) χ
2 p-value OR IC
-787
CC 138 96
1.383 0.515 # #
CT 2 0
-785
CC 140 94
2.942 0.16 # 0.00<2.79
CT 0 2
-599
CC 135 93
0.035 NS 1.15 0.23<6.23
CG 5 3
-517
CC 140 93
2.29 0.066 # 0.00<1.52
CG 0 3
-200
GG 138 89
3.86 0.033 0.18 0.03<1.00
GT 2 7
Table 5. Genotype distribution of the IFNG SNPs among TB patients and healthy controls (TST+).
Given that the SNP -200 IFNG was the only one that was associated with any of the studied
outcomes at genotype level, allele frequency was also tested for the same outcomes. Table 6
shows the comparison of the -200T variant between the stratified groups. The results confirm
the association with protection to the occurrence of active TB and, additionally to TBP.
Association of the -200T variant was also seen to occurrence of latent infection (p=0.035).
Different outcomes Groups SNP IFNG -200
P-valor* OR IC
Occurrence of TBactive Pacientes0.0071
TST+
0.036 0033 0.19 0.03<1.01
Occurrence pulmonary TB TBP0.0082
TST+
0.036 0.043 0.22 0.033<1.17
disease severity TBP0.0082
TBE
0.00 1.00 # #
latent infection TST+0.036
TST-
0.000 0.035 # #
Table 6. Distribution of allele frequencies of-200T variant mutant groups according to the different outcomes.
Finally, the more prevalent IFNG polymorphisms (-599C>G and-200G>T) were tested against
demographic variables, such as, gender and age. No significant association was found after
stratified analysis at allele, genotype or haplotype levels (data not shown).
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3.6. Association of the TNF–α SNPs and TB outcomes
Table 7 summarizes the distribution and comparison of genotype frequencies of each indi‐
vidual SNP among TB patients and TST+ controls. No significant difference was observed. The
evaluation of the possible association of different genotypes of TNF-α gene with susceptibility
to the occurrence of TBP or TBE was also carried out separately, however, no association was
found (data not shown).
Locus Genotype Patients(N=140)
Controls
TST+ (N= 96) p-valor OR IC
-646
GG 139 95
GA 1 1 1.00 0.68 0.02<25.33
-572
AA 138 95
CA 2 1 1.00 1.38 0.10<38.92
-422
CC 140 96
CT 0 0 - - -
-376
GG 127 93
GA 11 3 0.11 3.17 0.81<14.46
AA 2 0
-308
GG 118 83
GA 19 11 0.78 1.19 0.54<2.67
AA 3 2
-244
GG 136 92
GA 4 4 0.71 0.68 0.14<3.31
-238
GG 123 88
GA 15 8 0.47 1.50 0.58<3.97
AA 2 0
Table 7. Genotype distribution of the TNF-α SNPs among PTB patients and healthy controls (TST+).
Comparison of the TNF-α SNPs frequencies between TBP and TBEis shown in (Table 8). Only
the -572A>C (CA genotype) presented a significant difference between these groups, being
absent among the 121 TBP subjects, (RR = 8.12, CI = 5.20 <12.67 and p-value = 0.0175). The results
indicate a risk for disease severity. This association was confirmed upon allele frequency
evaluation (RR = 7.72, CI = 5.69 <10.47 and p = 0.0179) data not shown.
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Locus Genotype PTBN=121
TBE
N=19 p-value RR IC
-646 GG 120 19 1.00 0.00 0,00<115.2GA 1 0
-572 AA 121 17 0.0175 8.12 5.20<12.67AC 0 2
-422 CC 121 19 - - -CT 0 0
-376
GG 111 17
0.506 1.25 0.33<4.79GA 10 1
AA 0 1
-308
GG 101 17
0.392 0.63 0.16<2.54GA 18 1
AA 2 1
-244 GG 117 19 0.554 # #GA 4 0
-238
GG 106 17
0.585 0.85 0.22<3.37GA 14 1
AA 1 1
Table 8. Genotypes distribution of the TNF-α SNPs among TBP and TBE.
The association between the TNF-α genotypes with latent infection was also evaluated. No
significant difference was found (data not shown).
The final evaluation of independent SNPs with the different TB outcomes was performed
based in the allele frequencies comparison for the most common TNF-α SNPs (-376G>A,
-308G>A, -244G>A and -238G>A). The SNP -376G>A, allele variant -376A, showed a significant
association with susceptibility to the occurrence of active TB (p = 0.035, OR = 3.57, CI = 0.95 <
15.72) and severity (p = 0.038 and RR = 2.68) (Table 9). All other outcomes showed no significant
association with any of the variants tested, (data not shown).
Different outcomes Study Group SNP TNF-α -376A
p-valor OR IC
Occurrence of activeTB Patients(fa) 0.054
TST+
0.016 0.035 3.57 0.95<15.72
Occurrence of PTB PTB(fa) 0.041
TST+
0.016 0.201 2.72 0,68<12.62
Severity of disease PTB(fa) 0.041
TBE
0.052 0.038 2.68* 1.22<5.86
Latent infection TST+(fa) 0.016
TST-
0.017 0.90 0.623 0.12<7.86
Table 9. Distribution of allele frequency of the TNF-α -376A variant and association analysis with different outcomes
studied.
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Table 10 shows the distribution of the 14 identified haplotypes in the different groups used for
the association study. No significant difference was observed in the haplotypes frequencies
between groups (data not shown) and their distribution was quite homogeneous.
Haplotype General TBn= 140
PTB
n=121
EPTB
n=19
Controls PPD+
n=96
Controls PPD-
n=58
1 9567.9%) 82(67.8%) 0 70(72.9%) 40(69%)
2 2(1.4%) 1(0.8%) 0 0 0
3 19(13.6%) 17(14.1%) 2(10.5%) 11(11.5%) 7(12.1%)
4 1(0.7%) 0 1(5.26%) 0 1(1.72%)
5 3(2.1%) 3(2.5%) 0 4(4.2%) 2(3.4%)
6 7(5 %) 6(5%) 1(5.3%) 5(5.2%) 5(8.6%)
7 1(0.7%) 1(0.8%) 0 1(1.1%) 1(1.7%)
9 9(6%) 8(6.6%) 1(5.3%) 3(3.1%) 2(3.4%)
11 1(0.7%) 1(0.8%) 0 1(1.1%) 0
12 1(0.7%) 1(0.8%) 0 0 0
13 1(0.7%) 1(0.8%) 0 0 0
14 1(0.71%) 0 1(5.26%) 1(1.04%) 0
Table 10. Frequency of TNF-α haplotypes in the different groups studied
After the genotyping of all samples and evaluation of the possible association with the different
TB outcomes, the most frequent polymorphisms (-376G>A; -308G>A; -244G>A and -238G>A)
were tested in a stratified analysis against the demographic variables gender and age. No
significant differences were found for gender or age (data not shown).
4. Discussion
It is well known that to M. tuberculosis,  ethiologic agent of human TB can cause a broad
spectrum of effects ranging from no infection to different clinical disease phenotypes [2,
16,  23-25].  However,  the  reasons  for  individual  or  ethnic  differences  in  acquiring infec‐
tion,  active  disease,  disease  severity,  and  different  clinical  outcomes  have  not  been
completely clarified.  It  has long been realized that many human diseases arise from the
complex interplay between environmental exposures and host genetics susceptibilities [26].
In addition, several genetic factors have also been associated with different outcomes: host
susceptibility per se the occurrence of active TB, disease severity and / or protection for the
occurrence of active disease [27-33].
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The establishment of an efficient immune response involves many different molecules, among
which, cytokines and their receptors play an extremely important role. Thus, any genetic
alteration leading to changes in the regulation of gene expression may reflect this response. It
is known that the interindividual variation in the production of these molecules is directly
related to the genetic "background". Literature data have clearly demonstrated that genetic
variability of the genes encoding these molecules can affect the regulation of gene expression
positively or negatively influencing the final yield of the molecule in question. In the last
decade, several single nucleotide polymorphisms (SNPs) in the regulatory region of different
cytokine genes have been described and associated with susceptibility, severity or protection
for a growing number of diseases of different etiologies including tuberculosis [7, 34-35].
Among the possible genetic variations associated with an increased risk of developing TB,
there are several polymorphisms, mainly SNPs, in genes coding for cytokines, cytokine
receptors and several other molecules such as vitamin D receptor, NRAMP1 (SLC11A1), HLA
genes, etc.
The immune defense against M. tuberculosis is complex and involves the interaction between
T CD4+, T CD8+ lymphocytes, macrophages, and monocytes along with the production of
cytokines, such as interferon-γ (IFN-γ) and tumor necrosis factor-α (TNF-α) [36].
Convincing evidence indicating the importance of IFN-γ in particular, in the control of
mycobacterial infections has been found in both experimental and clinical studies [37-38].
Among the mainly important cytokines involved in TB progress after infection with M.
tuberculosis, TNF-α plays a key role. It is also a potent proinflammatory cytokine acting in
protection against intracellular pathogens [39-40].
The genetic variability of TNF-α and IFNG has been described in the last decade [41-46]
including association studies with tuberculosis. However, the frequencies of the polymor‐
phisms already described varies according to the ethnicity of the population studied, ham‐
pering the better interpretation of the value of association studies. Unfortunately, most of these
are performed in ethnically homogeneous populations, and therefore, many of the associations
described for a particular allelic variant in a certain gene may not represent genetic risk factor
in other populations. In Brazil, a country characterized by ethnically mixed population, there
are few data regarding the frequency of single nucleotide polymorphisms in these genes
(IFNG,TNF-α) and the few existing studies refers to one or two SNPs only. In view of the
importance of the promoter region with respect to regulation of gene expression, the major
goal of this work was to proceed a partial mapping of the promoter region of IFNG and TNF-
α genes (approximately, 800bp upstream of the transcription starting site) through PCR-
sequencing approach in samples from TB patients and healthy controls from Rio de Janeiro,
Brazil. Subsequently, based on frequencies of the different SNPs found individually for each
gene, we performed an association study with different TB outcomes.
4.1. Polymorphisms in the promoter region of IFNG and its association with TB
Characterization of the important portion within the IFNGwas firstly identified two decades
ago bydeletion analysisstudies [47-48]. According to authors, it comprises a highly conserved
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region from positions -117 to -47 and contains two sub regions that can be complexes with
proteins. The sub-proximal region (-90 to -65) shows strong homology to the IL-2 promoter
[49]. Several transcription factors activate transcription of IFNG by binding to this region.
Conversely, several others inhibit factors binds in other regions affecting transcription. Hence,
the interest in investigating the polymorphic sites within IFNG gene promoter, particularly
considering the importance of this cytokine in eliciting the immune response.
Here, analysis of the generated sequences identified seven polymorphic sites, four of which
were new. The transition C →T, was identified at position-787 from the transcription starting
site in five subjects, all heterozygous. The second C → T transition, previously described in the
data base of SNPs at position-785 was also found in five individuals, all heterozygous,
however, no reference to this SNP was found in the literature. The other three SNPs not yet
described, were C to G transition at position -599; C to T at position -517 and A to G at position
-255. Finally, two additional SNPs, transition from G to T at position -200 and A to G at position
-172, already described and well characterized [45] were found in our population.
One of the main problem found during this mapping was the confirmation of the identified
SNPs based on literature data and from different SNPs data bases available online because of
the lack of standardization regarding to the reference nucleotide to define the promoter region
(transcription starting site nt +1). Many authors describe the SNPs identified in relation to the
site of translation or use reference sequences containing sequencing errors leading to misclas‐
sification of SNPs (eg SNP-200G>T, originally described as -183 [45], later called as -179 [50]
and finally, confirmed in this study as -200). The current name, confirmed in this study is based
on the correction of the reference sequence used in previous studies and now available online.
These types of errors greatly hampered the beginning of the sequence analysis regarding the
identification of novel SNPs.
The frequency of each polymorphism was determined in the study population. As noted in
Table 1, the allele frequencies for all the identified SNPs were less than one percent, except for
the variants -599G and -200T, both in a frequency of 1.4%.
Functionally,  it  is  known that  polymorphisms (-200 and -172)  can affect  transcription of
the IFNG. The region from -213 to -200 induces transcription factor through (AP-1) [51]. A
polymorphism at this site (position -200, for example) must change the connection of AP-1
and the promoter activity in T cells. The polymorphism -172 is near to the nuclear factors-
activated T-cells site (NFAT site) (-186TAAAGGAAA-178) and should affect the stability
of this region [50].
The variant IFNG -200T is highly inducible by TNF-α and binds constitutively to nuclear
extracts obtained from T cells, whereas the allele -200G does not respond to TNF-α [50; 52].
The induction of transcriptional activity, when the T allele is present, increases protection
against tuberculosis. Our results corroborate these data, since the IFNG -200T variant showed
to be associated with protection the occurrence of active TB in our study group (P = 0.033, OR=
0.18, CI= 0.03 to 1.00).
According Bream,JH et al., 2002 [50], the promoter region of IFNG is highly conserved,
suggesting that these cytokine production variations are probably due to difference in binding
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to regulatory factors instead of polymorphisms in the gene, which is consistent with our
results. Only seven SNPs were found in our population, five of which were at a low frequency.
The polymorphisms found with a higher frequency were the -200G>T and -599C>G, the latter
being located between two putative binding sites of transcription factors. As this is not yet a
SNP described in the literature, functional studies are needed to better understand their
functional role. The SNP -200 is of great interest for association studies. However, this
polymorphism was not found in Caucasians or Indian populations, suggesting that different
selective forces may be operating in different ethnic or racial groups. These data corroborate
the evidence that IFN-γ is very important in the immune response and that mutations that
interfere with their production may influence the outcome of active tuberculosis as shown by
authors [28,31,53-54], and therefore, a selective force lead the gene to be so conserved.
4.2. Polymorphisms within the promoter region of TNF–α and their association with TB
TNF-α is a proinflammatory and immunoregulaty cytokine which plays a key role in the
initiation, regulation and perpetuation of host defense against infections, but is fatal in excess.
As this molecule plays an important role against a variety of pathogens involving different
patterns of risks and benefits, it is expected that several genetic elements are involved in its
control and production.
The levels of circulating TNF-α are regulated at transcriptional and post-transcriptional levels
and several polymorphisms within the promoter region of TNF-α have been associated with
altered circulating levels of this cytokine.
In humans, the TNF-α gene is located within the complex involving the human leukocyte
antigens (HLA), a highly polymorphic region on chromosome 6p21.3 and hence, many of TNF-
α polymorphisms are in linkage disequilibrium with the HLA genes. Because of differences in
the distribution of HLA alleles we might expect variations in associations between polymor‐
phisms of TNF-α and various conditions in different geographical areas.
The human genome analysis showed that the level of variations in the genome is approxi‐
mately one SNP/1.71Kb [55]. However, the TNF-α promoter has higher density of SNPs.
Despite this level of variation, the regions involved in gene regulation are highly conserved in
humans [56-58].
In our work, we perform the mapping of the first 800pb promoter region, through direct
sequencing of the amplified PCR product in 500 DNA samples from individuals living in the
metropolitan area of Rio de Janeiro, Brazil and found seven polymorphisms previously
described in the literature, most of which well characterized. However, according allele
frequencies, only the variants -376A, -308A, -238A and -244A were present in more than one
percent (0.030, 0.087, 0.011 and 0.050) respectively. The influence of these SNPs in binding of
transcription factors have not been fully explored, most of the studies are focused on the
association of one or two SNPs with different diseases. The SNPs -376, -308 and -238 have been
the most studied but, the results of functional studies performed so far for SNPs -308 and -238
are controversial. It is believed that the variant -308A is associated with an increased tran‐
scription rate, leading to an increased production of TNF-α [59] and the variant-238A with a
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decreased rate of transcription. Regarding the SNP-376G>A different studies show that this
polymorphism is located in a region of multiple interactions between proteins and DNA, and
that the minor allele acts in the recruitment of proteins OCT1 for this region. According Knight
et al (1999) [60] there is a significant interaction between variant -376A and the OCT-1 protein,
this variant binds the proteins while the variant -376G does not. The authors report also by
tests with the reporter gene system, that this mutant variant moderately increases the basal
levels of TNF-α and associate the same with a relative risk of 4 to cerebral malaria. The problem
is that the linkage disequilibrium is strong in this area and it is difficult to study the function
of an isolated SNP. In some Caucasian populations -376A allele variant is liked to -308G and
-238A [60-61], what is not observed in the African Gambia. Thus, association between the
linked allelic variants on TNF-α production and diseases has been studied. According, Hajeer&
Hutchinson (2001), the combined allele variants -238G, -308A and -376G are associated with
high TNF-α levels [62].
A large number of studies have investigated the association between polymorphisms in the
promoter region of the gene for TNF-α and tuberculosis. Results vary according to the different
populations studied, finding no association [63-72] or a positive association [26, 29, 73-75]. In
our analysis of the single SNP association, TB was associated with the -376G>A. In this case,
we observed an association of the minor allele -376A with the outcome of susceptibility per
se the occurrence of active TB (p= 0.035, OR 3.57, IC 0.95 <15.72) and an increased relative risk
for the occurrence of extrapulmonary TB (p= 0.038, OR 2.68, IC 1.22 < 5.86). The association of
this allele variant with the occurrence of TB and an increased relative risk for the development
of extrapulmonary TB is intriguing. Given the influence of this allele with increased expression
of TNF-α, one would expect an association with the protection. One possible explanation for
this observation may be the small sample size in the stratified groups. The large confidence
intervals (CI) for both outcomes could be a reflection of the small sample size.
The PCR-sequencing approach (gold standard) used for the mapping these genes practically
discard the possibility of genotyping errors and all mutants found for all SNPs evaluated were
confirmed twice by new PCR and resequencing. Another possibility would be due to the strong
linkage disequilibrium observed in this region of the gene promoter of TNF-α. It is possible
that other allelic variant (eg, 238A), as opposed to the functional role of variant -376A is
canceling the same level of control of gene expression.
An important aspect of this study relates to the ethnic characteristics of the studied population.
Brazilian population is characterized by mixture of ethnicities and the results obtained here
contribute for a global understanding of the influence of genetic factors in TB outcomes.
Usually, most of the studies on this field are made with ethnically homogeneous populations.
A study conducted by Baena et al., 2002 [76] clearly shows the importance of ethnic difference
in the association study of SNPs in TNF-α promoter with disease. According authors, the -857
SNP is a marker for Amerindians. In that study, SNPs in TNF-α promoter were also used to
identify markers of ancestry, understanding that this region was well characterized previously
with primates and humans. Several studies [77-81] have shown that some polymorphisms as
-238; - 244 and -308 are in association with the HLA genes and in addition, the SNPs -308 [77];
-863 and -857 [81], are markers of Caucasians. The -238 SNP was found in three populations
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studied, although it has also been found in Caucasians [78] and Asian [80]. Instead, the -376
SNP was not detected in any of the non-African analyzed and were found with the -238.
These data demonstrate the importance of taking into account the "background" of the
frequencies of SNPs of TNF-α in studies of gene-disease association.
Association studies of genetic factors with infectious diseases are difficult to conduct because
of the multi factorial nature of these diseases that includes host, pathogen and environmental
variables in different proportions for each disease. This multi factorial nature of TB stresses
the importance to look for haplotypes in the association studies. The fact that our population
is so mixed allowed us to find mutations that do not exist in other populations, such as the
-308, for example, which is relatively rare in Asians and American Indians. Data from the
genotyping of a large number of SNPs for different samples revealed that the human genome
has a block structure haplotype [82-83] and configuration of a haplotype sometimes is more
important than a single SNP genotype to determine phenotype [84]. Moreover, the construc‐
tion of a haplotype block is useful for identifying SNPs that isolates would not influence the
phenotype [85].
5. Conclusions
In conclusion, this study showed that the proximal part of the promoter region of IFNG is
highly conserved, as seen in previous publications and the identified SNPs were in very low
frequency. The -200T allele variant was associated with protection occurring active TB, and
pulmonary TB. In addition, this variant was also associated with latent infection. Concerning
TNF-α, the high genetic variability was confirmed, but only the -376G>A SNP showed an
association with susceptibility per se to TB occurrence and increased risk for the occurrence of
extrapulmonary TB.
The data presented here shows the reality of a population with characteristics of high ethnic
miscegenation, provides the different SNPs identified enabling the realization of real sample
calculation for any association studies that may be idealized with these targets and other
conditions for this population and finally, provides haplotype that can be used in other studies
of association with other diseases.
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